Drinking 3-5 cups of coffee per day could cut an individual's cardiovascular disease (CVD) mortality risk by up to 21%, according to research highlighted in a EuroPRevent session report published by the Institute for Scientific Information on Coffee (ISIC), a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health1.
The finding is significant given that coronary heart disease and stroke remain the primary cause of death across Europe, responsible for 51% of all deaths in women and 42% of all deaths in men.2 Over four million people die from CVD annually in Europe and overall, CVD is estimated to cost the EU economy €196 billion every year.3
The ISIC session report highlights the research presented at a Satellite Symposium held during the European Association for Cardiovascular Prevention & Rehabilitation's 2015 congress in Lisbon, Portugal, on the subject of 'Coffee and CVD Mortality'. Leading researchers in this field presented on the role of lifestyle factors in CVD mortality risk reduction, the epidemiological evidence on coffee and CVD mortality, and the conclusions from meta-analyses on coffee and CVD mortality.
Key highlights:
The report concludes that recent research supports the view that moderate coffee consumption at approximately 3 - 5 cups per day may have a protective effect against CVD mortality risk. The mechanisms of action behind the associations are unclear, however areas of interest for future research include the anti-inflammatory and antioxidant properties of coffee, and the known association between coffee consumption and type 2 diabetes risk reduction as CVD mortality is typically higher in this group. It is important to note that results differ between varying populations; it is suggested that 2 cups of coffee per day may offer the greatest protection in a Japanese population, whilst 3 cups may provide the greatest protection in UK and US populations.
Prof. Doutor António Vaz Carneiro of the Faculdade de Medicine da Universidade de Lisboa commented: "It is important to acknowledge factors which might have a protective effect against CVD mortality. Moderate coffee consumption could play a significant role in reducing CVD mortality risk which would impact health outcomes and healthcare spending across Europe."
The session report details the key scientific research presented by Assoc. Prof. Esther Lopez-Garcia, Prof. Alicja Wolk, and Prof. Carlo La Vecchia during a session titled: Coffee and CVD Mortality Risk, which took place on 14th May in Lisbon, Portugal.
###
To read the full report, please request a copy from Laura Blott - isic@kaizo.co.uk
For more information on coffee and cardiovascular health please visit http://www.coffeeandhealth.org .
References
1. Crippa A. et al. (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol . 180(8):763-75
2. Nichols M. et al. (2014) Cardiovascular disease in Europe 2014: epidemiological update. European Heart Journal . 35(42):2950-9
3. European Heart Network, 'European Cardiovascular Disease Statistics 2012' Available at: http://www.ehnheart.org/ cvd-statistics.html
4. Ding M. et al (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation . 129(6):643-59
5. Huxley R. et al. (2009) Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus. Archives of Internal Medicine . 169:2053-2063
6. Huxley R. et al. (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med . 169(22):2053-63
7. Akesson A. et al. (2014) Low-Risk Diet and Lifestyle Habits in the Primary Prevention of Myocardial Infarction in Men - A Population-Based Prospective Cohort Study. J Am Coll Cardiol . 64(13):1299-1306
8. Chomistek A.K. et al. (2015) Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol . 65(1):43-51
About ISIC
The Institute for Scientific Information on Coffee (ISIC) is a not-for-profit organization, established in 1990 and devoted to the study and disclosure of science related to "coffee and health." Since 2003 ISIC also supports a pan-European education programme, working in partnership with national coffee associations in nine countries to convey current scientific knowledge on "coffee and health" to health care professionals.
ISIC's activities are focused on:
ISIC respects scientific research ethics in all its activities. ISIC's communications are based on sound science and rely on evidence and scientific studies derived from peer-reviewed scientific journals and other publications.
ISIC members are seven of the major European coffee companies: DE Master Blenders 1753, illycaffè, Mondelez International, Lavazza, Nestlé, Paulig, and Tchibo.
About coffeeandhealth.org
The website http://www.coffeeandhealth.org is a science-based resource developed for health care and other professional audiences and provides the latest information and research into coffee, caffeine and health.
Follow us on twitter: @coffeeandhealth
For more information
Please contact:
Laura Blott
isic@kaizo.co.uk
+44 20 3176 4700